Impact of clonal hematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels
Lee, H.; Song, H.; Koh, Y.; Park, H. E.; Yoon, J. W.; Kim, M. J.; Chung, S.; Bae, J. H.; Choi, S. H.; Choi, S.-Y.; Koo, B.-K.
Show abstract
BackgroundClonal hematopoiesis of indeterminate potential (CHIP), defined as a clonal expansion of hematopoietic stem cells with age-related recurrent somatic mutations, has recently emerged as a novel cardiovascular risk factor. However, the pathogenic mechanism of CHIP in atherosclerotic cardiovascular disease (ASCVD) development is not yet fully understood. MethodsIn a cohort comprising 4,300 asymptomatic Korean participants aged 40-79 years, we investigated the risks associated with ASCVD by CHIP and the interplay of CHIP with other traditional risk factors for developing ASCVD. Using coronary computed tomography angiography (CCTA), we noninvasively assessed the changes in coronary arteries to evaluate CHIP-associated atherosclerosis. ResultsCHIP was present in 368 participants (8.6%). The most commonly mutated genes in CHIP included DNMT3A, TET2, and ASXL1. During follow-up (median, 4.7 years), 18 ASCVD cases (4.9%) were observed in CHIP carriers vs. 62 (1.6%) in non-carriers (p<0.001). The presence of CHIP was associated with an increased risk of ASCVD (adjusted hazard ratio [HR] 2.54, 95% confidence interval [CI] 1.48-4.37, p<0.001) after adjusting for other conventional cardiovascular risk factors. Particularly, in participants with high levels of low-density lipoprotein (LDL) cholesterol, CHIP enhanced the risk of ASCVD development (adjusted HR 4.18, 95% CI 1.99-8.77, p<0.001), demonstrating a significant synergism between CHIP and LDL cholesterol (S-index, 4.61; 95% CI 1.04-20.57, p=0.045). Serial CCTAs supported our findings by displaying de novo measurable coronary atherosclerosis with unstable plaque and in proximal lesions only in CHIP carriers with high LDL cholesterol. ConclusionThe presence of CHIP was significantly associated with the risk of ASCVD through synergy with LDL cholesterol in the general population, which might promote the early stage of coronary atherosclerosis.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The association between clonal hematopoiesis driver mutations, immune cell function and the vasculometabolic complications of obesity 96%
- Age-stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan 95%
- Development of a novel murine model of in-stent neoatherosclerosis 95%
Similar papers in this journal
- Polygenic Hyperlipidemias and Coronary Artery Disease Risk 95%
- Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes 95%
- LDLR Variant Classification for Improved Cardiovascular Risk Prediction in Familial Hypercholesterolemia 94%
Similar papers in this journal
- Transethnic meta-analysis of genome-wide association studies identifies three new loci and characterizes population-specific differences for coronary artery disease 95%
- A polygenic risk score for coronary heart disease performs well in individuals aged 70 years and older 95%
- A Polygenic Risk Score for Coronary Artery Disease Improves the Prediction of Early-Onset Myocardial Infarction and Mortality in Men 95%
Similar papers in this journal
- Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis 96%
- Female gene networks are expressed in myofibroblast-like smooth muscle cells in vulnerable atherosclerotic plaques. 95%
- Single-Cell Multimodal Profiling Reveals a Novel CD26+ Fibroblast Subpopulation in Atherosclerosis 94%
Similar papers in this journal
- Single-cell multimodal profiling of atherosclerosis identifies CD200 as a lineage marker of vascular smooth muscle cells and their derived cells 94%
- Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study 94%
- The environment-sensing aryl-hydrocarbon receptor inhibits the chondrogenic fate of modulated smooth muscle cells in atherosclerotic lesions 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.